Literature DB >> 21833828

Conformational changes in 2-trans-enoyl-ACP (CoA) reductase (InhA) from M. tuberculosis induced by an inorganic complex: a molecular dynamics simulation study.

André L P da Costa1, Ivani Pauli, Márcio Dorn, Evelyn K Schroeder, Chang-Guo Zhan, Osmar Norberto de Souza.   

Abstract

InhA, the NADH-dependent 2-trans-enoyl-ACP reductase enzyme from Mycobacterium tuberculosis (MTB), is involved in the biosynthesis of mycolic acids, the hallmark of mycobacterial cell wall. InhA has been shown to be the primary target of isoniazid (INH), one of the oldest synthetic antitubercular drugs. INH is a prodrug which is biologically activated by the MTB catalase-peroxidase KatG enzyme. The activation reaction promotes the formation of an isonicotinyl-NAD adduct which inhibits the InhA enzyme, resulting in reduction of mycolic acid biosynthesis. As a result of rational drug design efforts to design alternative drugs capable of inhibiting MTB's InhA, the inorganic complex pentacyano(isoniazid)ferrate(II) (PIF) was developed. PIF inhibited both wild-type and INH-resistant Ile21Val mutants of InhA and this inactivation did not require activation by KatG. Since no three-dimensional structure of the InhA-PIF complex is available to confirm the binding mode and to assess the molecular interactions with the protein active site residues, here we report the results of molecular dynamics simulations of PIF interaction with InhA. We found that PIF strongly interacts with InhA and that these interactions lead to macromolecular instabilities reflected in the long time necessary for simulation convergence. These instabilities were mainly due to perturbation of the substrate binding loop, particularly the partial denaturation of helices α6 and α7. We were also able to correlate the changes in the SASAs of Trp residues with the recent spectrofluorimetric investigation of the InhA-PIF complex and confirm their suggestion that the changes in fluorescence are due to InhA conformational changes upon PIF binding. The InhA-PIF association is very strong in the first 20.0 ns, but becomes very week at the end of the simulation, suggesting that the PIF binding mode we simulated may not reflect that of the actual InhA-PIF complex.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21833828     DOI: 10.1007/s00894-011-1200-7

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  43 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

Review 2.  Molecular dynamics simulations of biomolecules.

Authors:  Martin Karplus; J Andrew McCammon
Journal:  Nat Struct Biol       Date:  2002-09

3.  Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates collected in Australia.

Authors:  Caroline Lavender; Maria Globan; Aina Sievers; Helen Billman-Jacobe; Janet Fyfe
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

4.  Significance of root-mean-square deviation in comparing three-dimensional structures of globular proteins.

Authors:  V N Maiorov; G M Crippen
Journal:  J Mol Biol       Date:  1994-01-14       Impact factor: 5.469

5.  Satisfying hydrogen bonding potential in proteins.

Authors:  I K McDonald; J M Thornton
Journal:  J Mol Biol       Date:  1994-05-20       Impact factor: 5.469

6.  Activation of the pro-drug ethionamide is regulated in mycobacteria.

Authors:  A R Baulard; J C Betts; J Engohang-Ndong; S Quan; R A McAdam; P J Brennan; C Locht; G S Besra
Journal:  J Biol Chem       Date:  2000-09-08       Impact factor: 5.157

7.  Purification and biochemical characterization of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthases KasA and KasB.

Authors:  M L Schaeffer; G Agnihotri; C Volker; H Kallender; P J Brennan; J T Lonsdale
Journal:  J Biol Chem       Date:  2001-10-12       Impact factor: 5.157

8.  The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis.

Authors:  Y Zhang; B Heym; B Allen; D Young; S Cole
Journal:  Nature       Date:  1992-08-13       Impact factor: 49.962

Review 9.  Short-chain dehydrogenases/reductases (SDR).

Authors:  H Jörnvall; B Persson; M Krook; S Atrian; R Gonzàlez-Duarte; J Jeffery; D Ghosh
Journal:  Biochemistry       Date:  1995-05-09       Impact factor: 3.162

10.  Mechanism of thioamide drug action against tuberculosis and leprosy.

Authors:  Feng Wang; Robert Langley; Gulcin Gulten; Lynn G Dover; Gurdyal S Besra; William R Jacobs; James C Sacchettini
Journal:  J Exp Med       Date:  2007-01-16       Impact factor: 14.307

View more
  7 in total

1.  Mutations in catalase-peroxidase KatG from isoniazid resistant Mycobacterium tuberculosis clinical isolates: insights from molecular dynamics simulations.

Authors:  Arethusa Lobo Pimentel; Regiane Bertin de Lima Scodro; Katiany Rizzieri Caleffi-Ferracioli; Vera Lúcia Dias Siqueira; Paula Aline Zanetti Campanerut-Sá; Luciana Dias Ghiraldi Lopes; Aryadne Larissa de Almeida; Rosilene Fressatti Cardoso; Flavio Augusto Vicente Seixas
Journal:  J Mol Model       Date:  2017-03-16       Impact factor: 1.810

2.  Biochemical and cellular analysis of human variants of the DYT1 dystonia protein, TorsinA/TOR1A.

Authors:  Jasmin Hettich; Scott D Ryan; Osmar Norberto de Souza; Luís Fernando Saraiva Macedo Timmers; Shelun Tsai; Nadia A Atai; Cintia C da Hora; Xuan Zhang; Rashmi Kothary; Erik Snapp; Maria Ericsson; Kathrin Grundmann; Xandra O Breakefield; Flávia C Nery
Journal:  Hum Mutat       Date:  2014-07-17       Impact factor: 4.878

3.  Two birds with one stone? Possible dual-targeting H1N1 inhibitors from traditional Chinese medicine.

Authors:  Su-Sen Chang; Hung-Jin Huang; Calvin Yu-Chian Chen
Journal:  PLoS Comput Biol       Date:  2011-12-22       Impact factor: 4.475

4.  Slow-Onset Inhibition of Mycobacterium tuberculosis InhA: Revealing Molecular Determinants of Residence Time by MD Simulations.

Authors:  Benjamin Merget; Christoph A Sotriffer
Journal:  PLoS One       Date:  2015-05-21       Impact factor: 3.240

5.  A structural and energetic model for the slow-onset inhibition of the Mycobacterium tuberculosis enoyl-ACP reductase InhA.

Authors:  Huei-Jiun Li; Cheng-Tsung Lai; Pan Pan; Weixuan Yu; Nina Liu; Gopal R Bommineni; Miguel Garcia-Diaz; Carlos Simmerling; Peter J Tonge
Journal:  ACS Chem Biol       Date:  2014-03-10       Impact factor: 5.100

6.  Aqueous Molecular Dynamics Simulations of the M. tuberculosis Enoyl-ACP Reductase-NADH System and Its Complex with a Substrate Mimic or Diphenyl Ethers Inhibitors.

Authors:  Camilo Henrique da Silva Lima; Ricardo Bicca de Alencastro; Carlos Roland Kaiser; Marcus Vinícius Nora de Souza; Carlos Rangel Rodrigues; Magaly Girão Albuquerque
Journal:  Int J Mol Sci       Date:  2015-10-07       Impact factor: 5.923

7.  The importance of the quaternary structure to represent conformational ensembles of the major Mycobacterium tuberculosis drug target.

Authors:  Renata Fioravanti Tarabini; Luís Fernando Saraiva Macedo Timmers; Carlos Eduardo Sequeiros-Borja; Osmar Norberto de Souza
Journal:  Sci Rep       Date:  2019-09-23       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.